针对新出现的人畜共患伪狂犬病病毒的快速多用途反向遗传方法和可视化动物模型。

IF 4.5 2区 医学 Q1 PHARMACOLOGY & PHARMACY
Yu Zhang , Xiangtong Li , Juan Zhang , Yueyue Duan , Peibin Chen , Lei Shi , Cong Yuan , Liyan Cao , Maowen Sun , Yating Wang , Xiangyu Kong , Haixue Zheng , Qi Wang
{"title":"针对新出现的人畜共患伪狂犬病病毒的快速多用途反向遗传方法和可视化动物模型。","authors":"Yu Zhang ,&nbsp;Xiangtong Li ,&nbsp;Juan Zhang ,&nbsp;Yueyue Duan ,&nbsp;Peibin Chen ,&nbsp;Lei Shi ,&nbsp;Cong Yuan ,&nbsp;Liyan Cao ,&nbsp;Maowen Sun ,&nbsp;Yating Wang ,&nbsp;Xiangyu Kong ,&nbsp;Haixue Zheng ,&nbsp;Qi Wang","doi":"10.1016/j.antiviral.2024.106036","DOIUrl":null,"url":null,"abstract":"<div><div>Pseudorabies virus (PRV), a member of the Alphaherpesvirinae subfamily and a causative pathogen of Aujeszky's disease, has a broad host range including domestic and wild animals. PRV has been reported as a causative agent in patients with acute encephalitis in 2021, which suggests PRV might be a novel animal-origin virus in terms of zoonotic spillover and spread potential. To manage current PRV epidemics in pigs and prepare for future pandemics in other species including humans. Fundamental techniques essential for procuring such knowledge on prevention and therapy of PRV. Here, PRV CD22 strain was isolated and phylogenetic analysis showed that PRV CD22 belongs to the current epidemic strains in China. PRV CD22 was highly lethal to mice and piglets in vivo. Moreover, a rapid and efficient system to generate recombinant PRV was constructed based on PRV CD22 genomic DNA fosmid library. Using this system, a recombinant PRV strain expressing engineered labeling protein was rescued for visualization of viral infection in mouse model. Our study allows the generation of PRV that can be used for downstream treatment analyses. Once experimental or surveillance samples are obtained, PRV can be generated and treated efficiently based on our study.</div></div>","PeriodicalId":8259,"journal":{"name":"Antiviral research","volume":"232 ","pages":"Article 106036"},"PeriodicalIF":4.5000,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A rapid and versatile reverse genetic approach and visualization animal models for emerging zoonotic pseudorabies virus\",\"authors\":\"Yu Zhang ,&nbsp;Xiangtong Li ,&nbsp;Juan Zhang ,&nbsp;Yueyue Duan ,&nbsp;Peibin Chen ,&nbsp;Lei Shi ,&nbsp;Cong Yuan ,&nbsp;Liyan Cao ,&nbsp;Maowen Sun ,&nbsp;Yating Wang ,&nbsp;Xiangyu Kong ,&nbsp;Haixue Zheng ,&nbsp;Qi Wang\",\"doi\":\"10.1016/j.antiviral.2024.106036\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Pseudorabies virus (PRV), a member of the Alphaherpesvirinae subfamily and a causative pathogen of Aujeszky's disease, has a broad host range including domestic and wild animals. PRV has been reported as a causative agent in patients with acute encephalitis in 2021, which suggests PRV might be a novel animal-origin virus in terms of zoonotic spillover and spread potential. To manage current PRV epidemics in pigs and prepare for future pandemics in other species including humans. Fundamental techniques essential for procuring such knowledge on prevention and therapy of PRV. Here, PRV CD22 strain was isolated and phylogenetic analysis showed that PRV CD22 belongs to the current epidemic strains in China. PRV CD22 was highly lethal to mice and piglets in vivo. Moreover, a rapid and efficient system to generate recombinant PRV was constructed based on PRV CD22 genomic DNA fosmid library. Using this system, a recombinant PRV strain expressing engineered labeling protein was rescued for visualization of viral infection in mouse model. Our study allows the generation of PRV that can be used for downstream treatment analyses. Once experimental or surveillance samples are obtained, PRV can be generated and treated efficiently based on our study.</div></div>\",\"PeriodicalId\":8259,\"journal\":{\"name\":\"Antiviral research\",\"volume\":\"232 \",\"pages\":\"Article 106036\"},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2024-11-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Antiviral research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S016635422400247X\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Antiviral research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S016635422400247X","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

伪狂犬病毒(PRV)是阿尔法疱疹病毒亚科的成员,也是奥杰斯基病的致病病原体,其宿主范围很广,包括家畜和野生动物。据报道,PRV 是 2021 年急性脑炎患者的病原体,这表明 PRV 可能是一种新型的动物源病毒,具有人畜共患的外溢性和传播潜力。管理当前在猪中流行的 PRV,并为未来在包括人类在内的其他物种中流行做好准备。基础技术对于获得预防和治疗 PRV 的知识至关重要。本研究分离了 PRV CD22 株,系统进化分析表明 PRV CD22 属于目前中国流行的毒株。PRV CD22对小鼠和仔猪的体内致死率很高。此外,基于PRV CD22基因组DNA fosmid文库,构建了快速高效的PRV重组系统。利用该系统,重组 PRV 株系表达了工程标记蛋白,可用于小鼠模型中病毒感染的可视化。我们的研究能够产生可用于下游治疗分析的 PRV。一旦获得实验或监测样本,就可以根据我们的研究高效地生成和处理 PRV。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
A rapid and versatile reverse genetic approach and visualization animal models for emerging zoonotic pseudorabies virus
Pseudorabies virus (PRV), a member of the Alphaherpesvirinae subfamily and a causative pathogen of Aujeszky's disease, has a broad host range including domestic and wild animals. PRV has been reported as a causative agent in patients with acute encephalitis in 2021, which suggests PRV might be a novel animal-origin virus in terms of zoonotic spillover and spread potential. To manage current PRV epidemics in pigs and prepare for future pandemics in other species including humans. Fundamental techniques essential for procuring such knowledge on prevention and therapy of PRV. Here, PRV CD22 strain was isolated and phylogenetic analysis showed that PRV CD22 belongs to the current epidemic strains in China. PRV CD22 was highly lethal to mice and piglets in vivo. Moreover, a rapid and efficient system to generate recombinant PRV was constructed based on PRV CD22 genomic DNA fosmid library. Using this system, a recombinant PRV strain expressing engineered labeling protein was rescued for visualization of viral infection in mouse model. Our study allows the generation of PRV that can be used for downstream treatment analyses. Once experimental or surveillance samples are obtained, PRV can be generated and treated efficiently based on our study.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Antiviral research
Antiviral research 医学-病毒学
CiteScore
17.10
自引率
3.90%
发文量
157
审稿时长
34 days
期刊介绍: Antiviral Research is a journal that focuses on various aspects of controlling viral infections in both humans and animals. It is a platform for publishing research reports, short communications, review articles, and commentaries. The journal covers a wide range of topics including antiviral drugs, antibodies, and host-response modifiers. These topics encompass their synthesis, in vitro and in vivo testing, as well as mechanisms of action. Additionally, the journal also publishes studies on the development of new or improved vaccines against viral infections in humans. It delves into assessing the safety of drugs and vaccines, tracking the evolution of drug or vaccine-resistant viruses, and developing effective countermeasures. Another area of interest includes the identification and validation of new drug targets. The journal further explores laboratory animal models of viral diseases, investigates the pathogenesis of viral diseases, and examines the mechanisms by which viruses avoid host immune responses.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信